Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 652 | 0 | 0 | 0 | 0 |
| Gross Profit | 652 | 0 | N/A | N/A | N/A |
| Operating Expenses | 12,002 | 14,310 | 10,289 | 8,199 | 6,953 |
| Operating Income | -11,350 | -14,310 | -10,289 | -8,199 | -6,953 |
| Interest Expense | 185 | 160 | 120 | 89 | 92 |
| Other Income | -37 | -10 | -94 | 1 | 18 |
| Pre-tax Income | -11,572 | -14,480 | -10,503 | -8,287 | -7,027 |
| Net Income Continuous | -11,572 | -14,480 | -10,503 | -8,287 | -7,027 |
| Net Income | $-11,572 | $-14,480 | $-10,503 | $-8,287 | $-7,027 |
| EPS Basic Total Ops | -8.23 | -10.85 | -8.13 | -6.99 | -6.44 |
| EPS Basic Continuous Ops | -6.88 | -9.61 | -7.23 | -6.04 | -5.47 |
| EPS Diluted Total Ops | -8.23 | -10.85 | -8.13 | -6.99 | -6.44 |
| EPS Diluted Continuous Ops | -6.88 | -9.61 | -7.23 | -6.04 | -5.47 |
| EBITDA(a) | $-11,141 | $-14,106 | $-10,146 | $-8,060 | $-6,819 |